611 W. Union Street
Benson, AZ 85602
(520) 586-0800

LaFrontera
member support line
1-520-279-5737
M-F 5pm-8pm
24/7 weekends/holidays

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net
Medical Disorders
Resources
Basic InformationLookupsLatest News
Many U.S. Seniors May Need Better Knee Arthritis CareAfter COVID, Many Americans Are Struck by New Maladies: StudyCataracts: Common, and Easy to TreatThere Are Many Good Reasons for Kids to Get the COVID VaccineBabies Produce Strong Immune Response to Ward Off COVID-19: StudyNovavax's COVID Vaccine Shines in Latest TrialAHA News: U.S. Appears to Lose Ground in Controlling High Blood PressureOdds for Death, Hospital Care Rise When Statins Are StoppedWeight-Loss Surgeries Used Least in U.S. States That Need Them MostObesity Could Raise Odds for 'Long-Haul' COVID SymptomsSmokers, Obese People Need Major Heart Interventions Earlier in LifeOld Age No Bar to Successful Heart Transplant, Study FindsCOVID Antibody Treatment Is Safe, Effective in Transplant PatientsThere Is No 'Healthy Obesity,' Study FindsExpiration Dates on Johnson & Johnson COVID Vaccine ExtendedWill People Really Need a Yearly COVID Booster Vaccine?America Is Losing the War Against DiabetesGene Editing Technique Corrects Sickle Cell Disease in MiceCOVID Vaccines Appear Safe for People With IBDNew Treatment Fights Rare Cases of Vaccine-Linked Blood ClotsWoman Dies From Dengue Fever Acquired in FloridaAstraZeneca COVID Vaccine Tied to Rare Cases of Low Blood PlateletsWhy a COVID Diagnosis Could Cost You Way More Money in 2021New Links Between Poor Sleep, Diabetes and DeathVaccinations More Urgent as Variant That Crippled India Shows Up in the U.S.Think You Can Skip That Annual Physical?  Think AgainReal-World Study Shows Power of Pfizer, Moderna Vaccines to Prevent COVIDDeath Rates Are Rising Across Rural AmericaWhat Diet Is Most Likely to Help Ease Crohn's Disease?'Breakthrough' COVID Infections May Be Common in Vaccinated Transplant PatientsYour Teen's Smartphone Could Be Key to Unhealthy WeightToo Much Caffeine Might Raise Your Odds for GlaucomaPeople of Color Have Twice the Risk of Dying After Brain Injury, Study FindsStudy Pinpoints Cancer Patients at Highest Risk From COVIDMany Existing Drugs Could Be Potent COVID Fighters: StudyAntibiotics Won't Help Fight Lung-Scarring Disease IDF: StudyNew Disabilities Plague Half of COVID Survivors After Hospital DischargeDeclining Vaccination Rates Threaten Biden's July 4 GoalYour Doctor Appointments Might Look Different Post-PandemicPrior COVID Infection May Shield You From Another for at Least 10 MonthsTeens: You Got Your COVID Vaccine, What Now?White House Lists Countries Getting First Batch of Extra COVID VaccinesStrokes Hitting COVID Patients Are More Severe: StudyAverage COVID Hospital Bill for U.S. Seniors Nearly $22,000Deep Brain Stimulation Therapy May Help Parkinson's Patients Long TermNIH Starts Trial Assessing 'Mix & Match' COVID Vaccine ApproachAllergy Treatment Crucial If Your Child Has AsthmaScientists Discover Rare Form of ALS That Can Strike KidsGlobal Warming to Blame for 1 in 3 Heat-Related Deaths WorldwideBlood Sugar Tests Using Sweat, Not Blood? They Could Be on the Way
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

New Insights Into Treating Mild Head Injuries

HealthDay News
by Steven Reinberg
Updated: May 11th 2021

new article illustration

TUESDAY, May 11, 2021 (HealthDay News) -- It may be possible to treat the thinking problems that result from repeated hits to the head, a new laboratory study suggests.

The new experiments with mice are the first to offer a molecular analysis of what happens in the brain after repetitive but mild blows to the head, said researcher Mark Burns. He is head of the Laboratory for Brain Injury and Dementia at Georgetown University, in Washington, D.C.

"Most research in this area has been in mouse models with more severe brain injury, or in human brains with chronic traumatic encephalopathy (CTE)," Burns said in a university news release. "This means that we have been focusing only on how CTE pathology develops. Our goal was to understand how the brain changes in response to the low-level head impacts that many young football players, for example, are regularly experiencing."

Researchers have found that the average high school and college football player gets 21 head impacts per week, while some specialized players, such as defensive ends, experience twice as many, causing problems ranging from mild learning and memory deficits to behavioral changes that include aggression, impulsivity and sleep disorders.

"These findings represent a message of hope to athletes and their families who worry that a change in behavior and memory means that CTE is in their future," Burns said.

In the study, researchers mimicked the mild head impacts experienced by football players. The mice showed slower learning and impaired memory long after the head injuries had stopped. An analysis of the mouse brains found no inflammation or tau pathology, as usually seen in the brains of people with CTE.

The researchers then sequenced the RNA of the mouse brains. "All of our sequencing studies kept pointing to the same thing — the synapses that provide communication between neurons," said researcher Bevan Main, an assistant professor of neuroscience at Georgetown University.

The next step was to see how synaptic function was changed, said researcher Stephanie Sloley, a graduate of Georgetown's Interdisciplinary Program for Neuroscience. "The brain is wired via synaptic communication pathways, and while we found that these wires were intact, the way that they communicated using glutamate was blunted, repressed," Sloley explained.

Glutamate is a neurotransmitter in the brain found in more than 60% of brain synapses. It plays a role in the way the brain strengthens or weakens signals between neurons to shape learning and memory.

"Glutamate is usually very tightly regulated in the brain, but we know that head impacts cause a burst of glutamate to be released. We believe that the brain is adapting to the repeated bursts of glutamate caused by high frequency head impact, and dampens its normal response to glutamate, perhaps as a way to protect the neurons," Sloley said. She found a shift in the way that neurons detected and responded to glutamate, which reduced the neuron's ability to learn new information.

By giving some of the mice a drug to block glutamate before they had the series of head knocks, the investigators were able to confirm that glutamate was involved. The drug is already approved to treat Alzheimer's disease. In mice, the drug prevented cognitive ("thinking") problems.

According to Main, "This tells us that the cognitive issues we see in our head impact mice are occurring due to a change in the way the brain is working, and not because we have irreparable brain damage or CTE. It would be very unlikely that we would use a drug like this in young players as a neuroprotectant before they play sports because not all players will develop cognitive disorders. More likely is that we can use our findings to develop treatments that target the synapses and reverse this condition. That work is already underway."

The report was published May 10 in the journal Nature Communications.

More information

For more on CTE, head to the Alzheimer's Association.

SOURCE: Georgetown University Medical Center, news release, May 10, 2021